UNITED STATES

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NsWsXnj/59+y/r+7SG+hu3Occ8CMNZJqo5GxnoOG7LQn1tyjvecrnbifSYS0MY3A wd+GexJVOd66q+amuimoNA== 0000950005-07-000123.txt : 20070214 0000950005-07-000123.hdr.sgml : 20070214 20070214173037 ACCESSION NUMBER: 0000950005-07-000123 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070214 DATE AS OF CHANGE: 20070214 GROUP MEMBERS: ALIX MARDUEL GROUP MEMBERS: ALTA BIOPHARMA MANAGEMENT III, LLC GROUP MEMBERS: ALTA BIOPHARMA PARTNERS III GMBH & CO. BETEILIGUNGS KG GROUP MEMBERS: ALTA BIOPHARMA PARTNERS III, L. P. GROUP MEMBERS: ALTA CALIFORNIA MANAGEMENT PARTNERS II, LLC GROUP MEMBERS: ALTA CALIFORNIA MANAGEMENT PARTNERS II, LLC???NEW POOL GROUP MEMBERS: ALTA CALIFORNIA PARTNERS II, L. P. GROUP MEMBERS: ALTA CALIFORNIA PARTNERS II, L. P. ??? NEW POOL GROUP MEMBERS: ALTA EMBARCADERO BIOPHARMA PARTNERS III, LLC GROUP MEMBERS: ALTA EMBARCADERO PARTNERS II, LLC GROUP MEMBERS: ALTA PARTNERS GROUP MEMBERS: ALTA PARTNERS III, INC. GROUP MEMBERS: DANIEL JANNEY GROUP MEMBERS: EDWARD HURWITZ GROUP MEMBERS: EDWARD PENHOET GROUP MEMBERS: FARAH CHAMPSI GROUP MEMBERS: GARRETT GRUENER GROUP MEMBERS: GUY NOHRA GROUP MEMBERS: JEAN DELEAGE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEMORY PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001062216 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80464 FILM NUMBER: 07623004 BUSINESS ADDRESS: STREET 1: 100 PHILIPS PARKWAY CITY: MONTVALE STATE: NJ ZIP: 07645 BUSINESS PHONE: 2018027100 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ALTA PARTNERS CENTRAL INDEX KEY: 0001060013 IRS NUMBER: 943238854 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: ONE EMBARCADERO CENTER STREET 2: STE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 4153624022 MAIL ADDRESS: STREET 1: ONE EMBARCADERO CENTER STREET 2: STE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 SC 13G/A 1 p2006713g.htm SCHEDULE 13G/A UNITED STATES

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

(Amendment No. _1_)*

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Memory Pharmaceuticals Corporation

(Name of Issuer)

Common Stock

(Title of Class of Securities)

58606R403

(CUSIP Number)

December 31, 2006

(Date of Event That Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 58606R403

Page 2 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alta Partners & nbsp;

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

California &nbs p;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

IA &nb sp;

*SEE INSTRUCTION BEFORE FILLING OUT!

Footnote 1: The 3,767,528 shares includes the 895,655 shares of Common Stock and warrants to purchase 90,956 shares of Common Stock beneficially owned by Alta California Partners II, L.P., 10,241 shares of Common Stock and warrants to purchase 1,149 shares of Common stock beneficially owned by Alta Embarcadero Partners II, LLC, 394,737 shares of Common Stock and warrants to purchase 184,210 shares of Common Stock beneficially owned by Alta California Partners II, L.P.- New Pool, 1,605,110 shares of Common Stock and Warrants to purchase 401,277 shares of Common stock beneficially owned by Alta BioPharma Partners III, L.P., 107,798 shares of Common Stock and warrants to purchase 26,949 shares of Common Stock beneficially owned by Alta BioPharma Partners III GmbH & Co. Beteiligungs KG, and 39,557 shares of Common Stock and warrants to purchase 9,889 shares o f Common stock beneficially owned by Alta Embarcadero BioPharma Partners III, LLC.

CUSIP No. 58606R403

Page 3 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alta Partners III, Inc.

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

California &nbs p;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

IA &nb sp;

*SEE INSTRUCTION BEFORE FILLING OUT!

CUSIP No. 58606R403

Page 4 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alta California Partners II, L. P.

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

Delaware

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

PN &nb sp;

CUSIP No. 58606R403

Page 5 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alta California Management Partners II, LLC

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

Delaware

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

CO &nb sp;

CUSIP No. 58606R403

Page 6 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alta Embarcadero Partners II, LLC

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

California &nbs p;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

CO &nb sp;

CUSIP No. 58606R403

Page 7 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alta California Partners II, L. P. – New Pool

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

Delaware

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

PN &nb sp;

CUSIP No. 58606R403

Page 8 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alta California Management Partners II, LLC—New Pool

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

Delaware

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

CO &nb sp;

CUSIP No. 58606R403

Page 9 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alta BioPharma Partners III, L. P.

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

Delaware

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

PN &nb sp;

CUSIP No. 58606R403

Page 10 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alta BioPharma Management III, LLC

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

Delaware

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

CO &nb sp;

CUSIP No. 58606R403

Page 11 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alta BioPharma Partners III GmbH & Co. Beteiligungs KG

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

Germany & nbsp;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

CO &nb sp;

CUSIP No. 58606R403

Page 12 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alta Embarcadero BioPharma Partners III, LLC

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

California &nbs p;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

CO &nb sp;

CUSIP No. 58606R403

Page 13 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Jean Deleage &n bsp;

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

United States & nbsp;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

IN &nb sp;

*SEE INSTRUCTION BEFORE FILLING OUT!

CUSIP No. 58606R403

Page 14 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Garrett Gruener < /P>

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

United States & nbsp;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

1,576,948

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 1,576,948

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

1,576,948 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

2.32% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

IN &nb sp;

*SEE INSTRUCTION BEFORE FILLING OUT!

Footnote 1: The 1,576,948 shares includes the 895,655 shares of Common Stock and warrants to purchase 90,956 shares of Common Stock beneficially owned by Alta California Partners II, L.P., 10,241 shares of Common Stock and warrants to purchase 1,149 shares of Common stock beneficially owned by Alta Embarcadero Partners II, LLC, 394,737 shares of Common Stock and warrants to purchase 184,210 shares of Common Stock beneficially owned by Alta California Partners II, L.P.- New Pool.

CUSIP No. 58606R403

Page 15 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Daniel Janney & nbsp;

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

United States & nbsp;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

1,565,558

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 1,565,558

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

1,565,558 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

2.30% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

IN &nb sp;

*SEE INSTRUCTION BEFORE FILLING OUT!

Footnote 1: The 1,565,558 shares includes the 895,655 shares of Common Stock and warrants to purchase 90,956 shares of Common Stock beneficially owned by Alta California Partners II, L.P. and, 394,737 shares of Common Stock and warrants to purchase 184,210 shares of Common Stock beneficially owned by Alta California Partners II, L.P.- New Pool.

CUSIP No. 58606R403

Page 16 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Alix Marduel &n bsp;

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

United States & nbsp;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

3,767,528

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 3,767,528

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

3,767,528 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

5.51% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

IN &nb sp;

*SEE INSTRUCTION BEFORE FILLING OUT!

CUSIP No. 58606R403

Page 17 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Guy Nohra ;

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

United States & nbsp;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

1,576,948

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 1,576,948

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

1,576,948 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

2.32% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

IN &nb sp;

*SEE INSTRUCTION BEFORE FILLING OUT!

Footnote 1: The 1,576,948 shares includes the 895,655 shares of Common Stock and warrants to purchase 90,956 shares of Common Stock beneficially owned by Alta California Partners II, L.P., 10,241 shares of Common Stock and warrants to purchase 1,149 shares of Common stock beneficially owned by Alta Embarcadero Partners II, LLC, and 394,737 shares of Common Stock and warrants to purchase 184,210 shares of Common Stock beneficially owned by Alta California Partners II, L.P.- New Pool.

CUSIP No. 58606R403

Page 18 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Farah Champsi

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

United States & nbsp;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

2,190,580

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 2,190,580

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

2,190,580 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

3.22% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

IN &nb sp;

*SEE INSTRUCTION BEFORE FILLING OUT!

Footnote 1: The 2,190,580 shares includes the 1,605,110 shares of Common Stock and Warrants to purchase 401,277 shares of Common stock beneficially owned by Alta BioPharma Partners III, L.P., 107,798 shares of Common Stock and warrants to purchase 26,949 shares of Common Stock beneficially owned by Alta BioPharma Partners III GmbH & Co. Beteiligungs KG, and 39,557 shares of Common Stock and warrants to purchase 9,889 shares of Common stock beneficially owned by Alta Embarcadero BioPharma Partners III, LLC.

CUSIP No. 58606R403

Page 19 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Edward Hurwitz

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

United States & nbsp;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

2,190,580

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 2,190,580

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

2,190,580 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

3.22% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

IN &nb sp;

*SEE INSTRUCTION BEFORE FILLING OUT!

CUSIP No. 58606R403

Page 20 of 30 Pages

(1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons

Edward Penhoet

(2) Check The Appropriate Box If A Member Of A Group

(a)

(b)

(3)

SEC Use Only

(4)

Citizenship or Place of Organization

United States & nbsp;

Please see Attachment A & Footnote 1

Number Of Shares

(5)

Sole Voting Power

-0-

Beneficially Owned

By Each Reporting

(6)

Shared Voting Power

2,190,580

Person With

Please see Attachment A & Footnote 1

(7)

Sole Dispositive Power

-0-

(8)

Shared Dispositive Power 2,190,580

Please see Attachment A & Footnote 1

(9)

Aggregate Amount Beneficially Owned By Each Reporting Person

2,190,580 Please see Attachment A & Footnote 1

(10)

Check If The Aggregate Amount In Row (11) Excludes Certain Shares*

(11)

Percent Of Class Represented By Amount In Row (11)

3.22% Please see Attachment A & Footnote 1

(12)

Type Of Reporting Person

IN &nb sp;

*SEE INSTRUCTION BEFORE FILLING OUT!

Item 1.

(a)

Name of Issuer: Memory Pharmaceuticals, Inc. (“Issuer”)

(b)

Address of Issuer’s Principal Executive Offices:

100 Philips Parkway

Montvale, NJ 07645

Item 2.

(a)

Name of Person Filing:

Alta Partners (“AP”)

Alta Partners III, Inc. (“APIII”)

Alta California Partners II, L.P. (“ACPII”)

Alta California Partners II, L.P. – New Pool (“ACPII-NP”)

Alta California Management Partners II, LLC (“ACMPII”)

Alta California Management Partners II, LLC – New Pool (“ACMPII-NP”)

Alta Embarcadero Partners II, LLC (“AEPII”)

Alta BioPharma Partners III, L.P. (ABPIII”)

Alta BioPharma Management III, LLC (“ABMIII”)

Alta BioPharma Partners III GmbH & Co. Beteiligungs KG (“ABPIIIKG”)

Alta Embarcadero BioPharma Partners III, LLC (“AEBPIII”)

Jean Deleage (“JD”)

Garrett Gruener (“GG”)

Daniel Janney (“DJ”)

Alix Marduel (“AM”)

Guy Nohra (“GN”)

Farah Champsi (“FC”)

Edward Hurwitz (“EH”)

Edward Penhoet (“EP”)

(b)

Address of Principal Business Office:

One Embarcadero Center, Suite 3700

San Francisco, CA 94111

(c)

Citizenship/Place of Organization:

Entities:

California

ACPII

Delaware

ACPII-NP

Delaware

ACMPII

Delaware

ACMPII-NP

Delaware

AEPII

California

APIII

California

ABPIII

Delaware

ABMIII

Delaware

ABPIIIKG

Germany

AEBPIII

California

Individuals:

United States

(d)

Title of Class of Securities:

Common Stock

(e)

CUSIP Number: 58606R403

Item 3.

Not applicable.

Item 4

Ownership.

Please see Attachment A


		AP	APIII	ACPII	ACPII-NP	ACMPII	ACMPII-NP	AEPII
(a)	Beneficial Ownership	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528
(b)	Percentage of Class	5.51%	5.51%	5.51%	5.51%	5.51%	5.51%	5.51%
(c)	Sole Voting Power	-0-	-0-	-0-	-0-	-0-	-0-	-0-
	Shared Voting Power	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528
	Sole Dispositive Power	-0-	-0-	-0-	-0-	-0-	-0-	-0-
	Shared Dispositive Power	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528
		ABPIII	ABMIII	ABPIIIKG	AEBPIII	JD	GG	DJ
(a)	Beneficial Ownership	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528	1,576,948	1,565,558
(b)	Percentage of Class	5.51%	5.51%	5.51%	5.51%	5.51%	2.32%	2.30%
(c)	Sole Voting Power	-0-	-0-	-0-	-0-	-0-	-0-	-0-
	Shared Voting Power	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528	1,576,948	1,565,558
	Sole Dispositive Power	-0-	-0-	-0-	-0-	-0-	-0-	-0-
	Shared Dispositive Power	3,767,528	3,767,528	3,767,528	3,767,528	3,767,528	1,576,948	1,565,558


		AM	GN	FC	EH	EP
(a)	Beneficial Ownership	3,767,528	1,576,948	2,190,580	2,190,580	2,190,580
(b)	Percentage of Class	5.51%	2.32%	3.22%	3.22%	3.22%
(c)	Sole Voting Power	-0-	-0-	-0-	-0-	-0-
	Shared Voting Power	3,767,528	1,576,948	2,190,580	2,190,580	2,190,580
	Sole Dispositive Power	-0-	-0-	-0-	-0-	-0-
	Shared Dispositive Power	3,767,528	1,576,948	2,190,580	2,190,580	2,190,580

Item 5.

Ownership of Five Percent or Less of a Class

Not Applicable.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.

Item 8.

Identification and Classification of Members of the Group

No reporting person is a member of a group as defined in Section 240.13d-1(b)(1)(ii)(H) of the Act.

Item 9.

Notice of Dissolution of Group

Not applicable.

Item 10.

Certification

By signing below we certify that, to the best of our knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

EXHIBITS

Joint Filing Statement

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date:

February 14, 2007

ALTA PARTNERS

ALTA CALIFORNIA PARTNERS II, L.P.

By: Alta California Management Partners II, LLC,

Its General Partner

By: /s/ Jean Deleage

By: /s/ Guy Nohra

Jean Deleage, President

Guy Nohra, Member

ALTA CALIFORNIA MANAGEMENT PARTNERS II, LLC

ALTA EMBARCADERO PARTNERS II, LLC

By: /s/ Guy Nohra

Guy Nohra, Member

ALTA CALIFORNIA PARTNERS II, L.P. – NEW POOL

By: Alta California Management Partners II, LLC -

New Pool, Its General Partner

By: /s/ Guy Nohra

Guy Nohra, Managing Director

ALTA CALIFORNIA MANAGEMENT PARTNERS II, LLC –NEW POOL

By: /s/ Guy Nohra

Guy Nohra, Managing Director

/s/ Jean Deleage

/s/ Guy Nohra

Jean Deleage

Guy Nohra

/s/ Garrett Gruener

/s/ Alix Marduel

Garrett Gruener

Alix Marduel

/s/ Daniel Janney

Daniel Janney

ALTA PARTNERS III, INC.

By: /s/ Jean Deleage

Jean Deleage, President

ALTA BIOPHARMA PARTNERS III, L.P.

ALTA BIOPHARMA MANAGEMENT III, LLC

By: Alta BioPharma Management III, LLC

By: /s/ Alix Marduel

Alix Marduel, Director

ALTA EMBARCADERO BIOPHARMA PARTNERS III, LLC

ALTA BIOPHARMA PARTNERS III GMBH &CO.

BETEILIGUNGS KG

By: Alta BioPharma Management III, LLC

By: /s/ Alix Marduel

/s/ Alix Marduel

Alix Marduel, Manager

Alix Marduel, Director

/s/ Jean Deleage

/s/ Farah Champsi

Jean Deleage

Farah Champsi

/s/ Alix Marduel

/s/ Edward Hurwitz

Alix Marduel

Edward Hurwitz

/s/ Edward Penhoet

Edward Penhoet

EXHIBIT A

AGREEMENT OF JOINT FILING

Date:

February 14, 2007

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

ALTA PARTNERS

ALTA CALIFORNIA PARTNERS II, L.P.

By: Alta California Management Partners II, LLC,

Its General Partner

By: /s/ Jean Deleage

By: /s/ Guy Nohra

Jean Deleage, President

Guy Nohra, Member

ALTA CALIFORNIA MANAGEMENT PARTNERS II, LLC

ALTA EMBARCADERO PARTNERS II, LLC

By: /s/ Guy Nohra

Guy Nohra, Member

ALTA CALIFORNIA PARTNERS II, L.P. – NEW POOL

By: Alta California Management Partners II, LLC -

New Pool, Its General Partner

By: /s/ Guy Nohra

Guy Nohra, Managing Director

ALTA CALIFORNIA MANAGEMENT PARTNERS II, LLC –NEW POOL

By: /s/ Guy Nohra

Guy Nohra, Managing Director

/s/ Jean Deleage

/s/ Guy Nohra

Jean Deleage

Guy Nohra

/s/ Garrett Gruener

/s/ Alix Marduel

Garrett Gruener

Alix Marduel

/s/ Daniel Janney

Daniel Janney

ALTA PARTNERS III, INC.

By: /s/ Jean Deleage

Jean Deleage, President

ALTA BIOPHARMA PARTNERS III, L.P.

ALTA BIOPHARMA MANAGEMENT III, LLC

By: Alta BioPharma Management III, LLC

By: /s/ Alix Marduel

Alix Marduel, Director

ALTA EMBARCADERO BIOPHARMA PARTNERS III, LLC

ALTA BIOPHARMA PARTNERS III GMBH &CO.

BETEILIGUNGS KG

By: Alta BioPharma Management III, LLC

By: /s/ Alix Marduel

/s/ Alix Marduel

Alix Marduel, Manager

Alix Marduel, Director

/s/ Jean Deleage

/s/ Farah Champsi

Jean Deleage

Farah Champsi

/s/ Alix Marduel

/s/ Edward Hurwitz

Alix Marduel

Edward Hurwitz

/s/ Edward Penhoet

Edward Penhoet

Attachment A

Alta Partners provides investment advisory services to several venture capital funds including Alta California Partners II, L.P., Alta Embarcadero Partners II, LLC and Alta California Partners II, LLC-New Pool. On November 29, 2006, Alta California Partners II, L.P. sold 298,551 shares of Common Stock, and now beneficially owns 895,655 shares of Common Stock and warrants to purchase 90,956 shares of Common Stock. On November 29, 2006, Alta Embarcadero Partners II, LLC sold 3,413 shares of Common Stock and now beneficially owns 10,241 shares of Common Stock and warrants to purchase 1,149 shares of Common Stock. On November 29, 2006, Alta California Partners II, L.P.- New Pool sold 131,579 shares of Common Stock and now beneficially owns 394,737 shares of Common Stock and warrants to purchase 184,210 shares of Common Stock. The respective general partners and members of Alta California Partners II, L.P., Alta Embarcadero Partners II, LLC and Alta California Partn ers II, L.P.-New Pool exercise sole voting and investment power in respect to the shares owned by such funds.

Certain principals of Alta Partners are members of Alta California Management Partners II, LLC (which is a general partner of Alta California Partners II, L.P.), members of Alta Embarcadero Partners II, LLC., and managing directors of Alta California Management Partners II, LLC-New Pool (which is the general partner of Alta California Partners II, L.P.-New Pool). As members and managing directors of such entities, they may be deemed to share voting and investment powers over the shares held by such funds. The principals of Alta Partners disclaim beneficial ownership of all such shares held by the foregoing funds, except to the extent of their proportionate pecuniary interests therein.

Mr. Jean Deleage is a member of Alta California Management Partners II, LLC (which is the general partner of Alta California Partners II, L.P.) , a member of Alta Embarcadero Partners II, LLC, and a managing director of Alta California Management Partners II, LLC-New Pool (which is the general partner of Alta California Partners II, L.P.-New Pool). Thus, he currently shares voting and dispositive powers over the 895,655 shares of Common Stock and warrants to purchase 90,956 shares of Common Stock beneficially owned by Alta California Partners II, L.P., the 10,241 shares of Common Stock and warrants to purchase 1,149 shares of Common Stock beneficially owned by Alta Embarcadero Partners II, LLC, and the 394,737 shares of Common Stock and warrants to purchase 184,210 shares of Common Stock beneficially owned by Alta California Partners II, L.P.- New Pool. He disclaims beneficial ownership of all such shares held by the foregoin g funds except to the extent of his proportionate pecuniary interests therein.

Mr. Guy Nohra is a member of Alta California Management Partners II, LLC (which is the general partner of Alta California Partners II, L.P.) , a member of Alta Embarcadero Partners II, LLC, and a managing director of Alta California Management Partners II, LLC-New Pool (which is the general partner of Alta California Partners II, L.P.-New Pool). Thus, he currently shares voting and dispositive powers over the 895,655 shares of Common Stock and warrants to purchase 90,956 shares of Common Stock beneficially owned by Alta California Partners II, L.P., the 10,241 shares of Common Stock and warrants to purchase 1,149 shares of Common Stock beneficially owned by Alta Embarcadero Partners II, LLC, and the 394,737 shares of Common Stock and warrants to purchase 184,210 shares of Common Stock beneficially owned by Alta California Partners II, L.P.- New Pool. He disclaims beneficial ownership of all such shares held by the foregoing funds except to the extent of his proportionate p ecuniary interests therein.

Mr. Garrett Gruener is a member of Alta California Management Partners II, LLC (which is the general partner of Alta California Partners II, L.P.) , a member of Alta Embarcadero Partners II, LLC, and a managing director of Alta California Management Partners II, LLC-New Pool (which is the general partner of Alta California Partners II, L.P.-New Pool). Thus, he currently shares voting and dispositive powers over the 895,655 shares of Common Stock and warrants to purchase 90,956 shares of Common Stock beneficially owned by Alta California Partners II, L.P., the 10,241 shares of Common Stock and warrants to purchase 1,149 shares of Common Stock beneficially owned by Alta Embarcadero Partners II, LLC, and the 394,737 shares of Common Stock and warrants to purchase 184,210 shares of Common Stock beneficially owned by Alta California Partners II, L.P.- New Pool. He disclaims beneficial ownership of all such shares held by the foregoing funds except to the extent of his proportio nate pecuniary interests therein.

Daniel Janney is a member of Alta California Management Partners II, LLC (which is the general partner of Alta California Partners II, L.P.) , and a managing director of Alta California Management Partners II, LLC-New Pool (which is the general partner of Alta California Partners II, L.P.-New Pool). Thus, he currently shares voting and dispositive powers over the 895,655 shares of Common Stock and warrants to purchase 90,956 shares of Common Stock beneficially owned by Alta California Partners II, L.P., and the 394,737 shares of Common Stock and warrants to purchase 184,210 shares of Common Stock beneficially owned by Alta California Partners II, L.P.- New Pool. He disclaims beneficial ownership of all such shares held by the foregoing funds except to the extent of his proportionate pecuniary interests therein.

Dr. Alix Marduel is a member of Alta California Management Partners II, LLC (which is the general partner of Alta California Partners II, L.P) , a member of Alta Embarcadero Partners II, LLC, and a managing director of Alta California Management Partners II, LLC-New Pool (which is the general partner of Alta California Partners II, L.P.-New Pool). Thus, she currently shares voting and dispositive powers over the 895,655 shares of Common Stock and warrants to purchase 90,956 shares of Common Stock beneficially owned by Alta California Partners II, L.P., the 10,241 shares of Common Stock and warrants to purchase 1,149 shares of Common Stock beneficially owned by Alta Embarcadero Partners II, LLC, and the 394,737 shares of Common Stock and warrants to purchase 184,210 shares of Common Stock beneficially owned by Alta California Partners II, L.P.- New Pool. She disclaims beneficial ownership of all such shares held by the foregoing funds except to the extent of her proportiona te pecuniary interests therein.

Alta Partners III, Inc. provides investment advisory services to several venture capital funds including Alta BioPharma Partners III, L.P., Alta BioPharma Partners III GmbH & Co. Beteiligungs KG and Alta Embarcadero BioPharma Partners III, LLC. Alta BioPharma Partners III, L.P. beneficially owns 1,605,110 shares of Common Stock and warrants to purchase 401,277 shares of Common Stock, Alta BioPharma Partners III GmbH & Co. Beteiligungs KG beneficially owns 107,798 shares of Common Stock and warrants to purchase 26,949 shares of Common Stock, and Alta Embarcadero BioPharma Partners III, LLC beneficially owns 39,557 shares Common Stock and warrants to purchase 9,889 shares of Common Stock. The general partner of Alta BioPharma Partners III, L.P., the managing limited partner of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG, and the managers of Alta Embarcadero BioPharma Partners III, LLC exercise sole voting and investment power in respect to the shares o wned by such funds.

Certain principals of Alta Partners III, Inc. are directors of Alta BioPharma Management III, LLC (which is the general partner of Alta BioPharma Partners III, L.P. and the managing limited partner of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG), and managers of Alta Embarcadero BioPharma Partners III, LLC. As directors and managers of such entities, they may be deemed to share voting and investment powers over the shares beneficially held by the funds. The principals of Alta Partners III, Inc. disclaim beneficial ownership of all such shares held by the foregoing funds, except to the extent of their proportionate pecuniary interests therein.

Ms. Farah Champsi is a director of Alta BioPharma Management III, LLC (which is the general partner of Alta BioPharma Partners III, L.P. and the managing limited partner of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG), and a manager of Alta Embarcadero BioPharma Partners III, LLC. Thus, she currently shares voting and dispositive powers over the 1,605,110 shares of Common Stock and warrants to purchase 401,277 shares of Common Stock beneficially owned by Alta BioPharma Partners III, L.P., the 107,798 shares of Common Stock and warrants to purchase 26,949 shares of Common Stock beneficially owned by Alta BioPharma Partners III GmbH & Co. Beteiligungs KG, and the 39,557 shares of Common Stock and warrants to purchase 9,889 shares of Common Stock beneficially owned by Alta Embarcadero BioPharma Partners III, LLC. She disclaims beneficial ownership of all such shares held by all of the foregoing funds except to the extent of her proportionate pecuniary inter ests therein.

Mr. Jean Deleage is a director of Alta BioPharma Management III, LLC (which is the general partner of Alta BioPharma Partners III, L.P. and the managing limited partner of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG), and a manager of Alta Embarcadero BioPharma Partners III, LLC. Thus, he currently shares voting and dispositive powers over the 1,605,110 shares of Common Stock and warrants to purchase 401,277 shares of Common Stock beneficially owned by Alta BioPharma Partners III, L.P., the 107,798 shares of Common Stock and warrants to purchase 26,949 shares of Common Stock beneficially owned by Alta BioPharma Partners III

GmbH & Co. Beteiligungs KG, and the 39,557 shares of Common Stock and warrants to purchase 9,889 shares of Common Stock beneficially owned by Alta Embarcadero BioPharma Partners III, LLC. He disclaims beneficial ownership of all such shares held by all of the foregoing funds except to the extent of his proportionate pecuniary interests therein.

Dr. Alix Marduel is a director of Alta BioPharma Management III, LLC (which is the general partner of Alta BioPharma Partners III, L.P. and the managing limited partner of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG), and the managing limited partner of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG),

and a manager of Alta Embarcadero BioPharma Partners III, LLC. Thus, she currently shares voting and dispositive powers over the 1,605,110 shares of Common Stock and warrants to purchase 401,277 shares of Common Stock beneficially owned by Alta BioPharma Partners III, L.P., the 107,798 shares of Common Stock and warrants to purchase 26,949 shares of Common Stock beneficially owned by Alta BioPharma Partners III GmbH & Co. Beteiligungs KG, and the 39,557 shares of Common Stock and warrants to purchase 9,889 shares of Common Stock beneficially owned by Alta Embarcadero BioPharma Partners III, LLC. She disclaims beneficial ownership of all such shares held by all of the foregoing funds except to the extent of her proportionate pecuniary interests therein.

Mr. Edward Hurwitz is a director of Alta BioPharma Management III, LLC (which is the general partner of Alta BioPharma Partners III, L.P. and the managing limited partner of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG), and a manager of Alta Embarcadero BioPharma Partners III, LLC. Thus, he currently shares voting and dispositive powers over the 1,605,110 shares of Common Stock and warrants to purchase 401,277 shares of Common Stock beneficially owned by Alta BioPharma Partners III, L.P., the 107,798 shares of Common Stock and warrants to purchase 26,949 shares of Common Stock beneficially owned by Alta BioPharma Partners III GmbH & Co. Beteiligungs KG, and the 39,557 shares of Common Stock and warrants to purchase 9,889 shares of Common Stock beneficially owned by Alta Embarcadero BioPharma Partners III, LLC. He disclaims beneficial ownership of all such shares held by all of the foregoing funds except to the extent of his propor tionate pecuniary interests therein.

Mr. Edward Penhoet is a director of Alta BioPharma Management III, LLC (which is the general partner of Alta BioPharma Partners III, L.P. and the managing limited partner of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG), and a manager of Alta Embarcadero BioPharma Partners III, LLC. Thus, he currently shares voting and dispositive powers over the 1,605,110 shares of Common Stock and warrants to purchase 401,277 shares of Common Stock beneficially owned by Alta BioPharma Partners III, L.P., the 107,798 shares of Common Stock and warrants to purchase 26,949 shares of Common Stock beneficially owned by Alta BioPharma Partners III GmbH & Co. Beteiligungs KG, and the 39,557 shares of Common Stock and warrants to purchase 9,889 shares of Common Stock beneficially owned by Alta Embarcadero BioPharma Partners III, LLC. He disclaims beneficial ownership of all such shares held by all of the foregoing funds except to the extent of his propor tionate pecuniary interests therein.

Alta Partners and Alta Partners III, Inc. are venture capital firms that share an office in San Francisco.

Alta Partners is California Corporation

Alta Partners III, Inc. is a California Corporation.

Alta California Partners II, L.P. is a Delaware Limited Partnership

Alta California Management Partners II, LLC is a Delaware Limited Liability Company

Alta Embarcadero Partners II, LLC is a California Limited Liability Company

Alta California Partners II, L.P. - New Pool is a Delaware Limited Partnership.

Alta California Management Partners II, LLC – New Pool is a Delaware Limited Liability Company

Alta BioPharma Partners III, L.P. is a Delaware Limited Partnership

Alta BioPharma Management III, LLC is a Delaware Limited Liability Company

Alta BioPharma Partners III GmbH & Co. Beteiligungs KG is a German Limited Partnership

Alta Embarcadero BioPharma Partners III, LLC is a California Limited Liability Company.

-----END PRIVACY-ENHANCED MESSAGE-----